COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,895 Articles (22,568 medRxiv, 8,327 bioRxiv)

Most recent first Previous |  Page 1485: Articles 14841-14850  | Next

Epidemiological characteristics and incubation period of SARS-CoV-2 during the 2020-2021 winter pandemic wave in north China: an observational study
Liu, T., Chen, Z., Xu, J.
10.1101/2021.05.08.21256896 — Posted: 2021-05-18
Performance evaluation of the BD SARS-CoV-2 reagents for the BD MAX™ system
Yanson, K., LaViers, W., Neely, L., Lockamy, E., Castillo-Hernandez, L. C., Oldfied, C., Ackerman, R., Ackerman, J., Ortiz, D., Pacheco, S., Simner, P., Young, S., McElvania, E., Lin, Y.-C., Cooper, C.
10.1101/2021.05.12.21257120 — Posted: 2021-05-18
Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19
Lucchetta, M., Pellegrini, M.
10.1101/2021.05.13.21257140 — Posted: 2021-05-18 Discussion: Onsite
The effect of smaller classes on infection-related school absence: Evidence from the Project STAR randomized controlled trial
von Hippel, P. T.
10.1101/2021.05.16.21257297 — Posted: 2021-05-18
Viability of MS2 and Phi6 Bacteriophages on Carpet and Dust
Nastasi, N., Renninger, N., Bope, A., Cochran, S. J., Greaves, J., Haines, S. R., Balasubrahmaniam, N., Stuart, K., Panescu, J., Bibby, K., Hull, N. M., Dannemiller, K. C.
10.1101/2021.05.17.444479 — Posted: 2021-05-18
Longitudinal changes in home-based arts engagement during and following the first national lockdown due to the COVID-19 pandemic in the United Kingdom
Bu, F., Mak, H. W., Bone, J. K., Fancourt, D.
10.1101/2021.05.14.21257233 — Posted: 2021-05-18
Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study
Rosello, A., Barnard, R. C., Smith, D. R. M., Evans, S., Grimm, F., Davies, N. G., Centre for Mathematical Modelling of Infectious Diseases COVID-19 modelling working group, , Deeny, S. R., Knight, G. M., Edmunds, W. J.
10.1101/2021.05.17.21257315 — Posted: 2021-05-18
THE US MIDLIFE MORTALITY CRISIS CONTINUES: INCREASED DEATH RATES FROM CAUSES OTHER THAN COVID-19 DURING 2020
Glei, D. A.
10.1101/2021.05.17.21257241 — Posted: 2021-05-18
Mitigating the psychological impacts of COVID-19 restrictions: The Behavioural Activation in Social Isolation (BASIL) pilot randomised controlled trial to prevent depression and loneliness among older people with long term conditions
Gilbody, S., Littlewood, E., McMillan, D., Chew-Graham, C., Bailey, D., Gascoyne, S., Sloane, C., Burke, L., Coventry, P., Crosland, S., Fairhurst, C., Henry, A., Hewitt, C., Joshi, K., Ryde, E., Shearsmith, L., Traviss-Turner, G., Woodhouse, R., Clegg, A., Gentry, T., Hill, A. J., Lovell, K., Dexter-Smith, S., Webster, J., Ekers, D.
10.1101/2021.05.17.21257309 — Posted: 2021-05-18
Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations
Shen, L., Dien Bard, J., Triche, T. J., Judkins, A. R., Biegel, J. A., Gai, X.
10.1101/2021.05.14.21257247 — Posted: 2021-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).